Treatment of Multiple Myeloma in Elderly Patients: A Review of Literature and Practice Guidelines.
| Autor: | Manapuram S; Internal Medicine, Saint Francis Hospital and Medical Center, Grand Island, USA., Hashmi H; Oncology, University of Louisville School of Medicine, Louisville, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2018 Dec 01; Vol. 10 (12), pp. e3669. Date of Electronic Publication: 2018 Dec 01. |
| DOI: | 10.7759/cureus.3669 |
| Abstrakt: | Multiple myeloma (MM) is a clonal disorder of malignant plasma cells that comprises approximately 10% of hematologic malignancies. With median age of 66 at the time of presentation, multiple myeloma is predominantly a disease of the elderly. The availability of new combination regimens and the enhanced safety of autologous hematopoietic stem cell transplant has increased the treatment options for elderly patients with multiple myeloma. We provide a summary of data supporting the current management of elderly patients with newly diagnosed multiple myeloma. Competing Interests: The authors have declared that no competing interests exist. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|